Literature DB >> 2572697

Multiple percutaneous transluminal angioplasties and low dose pulse methotrexate for Takayasu's arteritis.

G C Liang1, R Nemickas, M Madayag.   

Abstract

A 20-year-old woman developed left shoulder and arm claudication and angiographic evidence of Takayasu's arteritis. She obtained temporary relief from percutaneous transluminal angioplasties 6 times. Her symptoms were finally controlled with low dose oral pulse methotrexate. This is the first case report of Takayasu's arteritis treated successfully with low-dose pulse methotrexate.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2572697

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  5 in total

1.  Methotrexate eluting stents: to modify or cure?

Authors:  A C Morton; J Gunn
Journal:  Heart       Date:  2004-02       Impact factor: 5.994

2.  Mycophenolate mofetil reduces disease activity and steroid dosage in Takayasu arteritis.

Authors:  Samuel K Shinjo; Rosa M R Pereira; Vivian A P Tizziani; Ari S Radu; Maurício Levy-Neto
Journal:  Clin Rheumatol       Date:  2007-02-28       Impact factor: 2.980

3.  Effectiveness and safety of methotrexate versus leflunomide in 12-month treatment for Takayasu arteritis.

Authors:  Chunling Wu; Ying Sun; Xiaomeng Cui; Sifan Wu; Lili Ma; Huiyong Chen; Yan Yan; Zongfei Ji; Yun Liu; Jiang Lin; Peng Lv; Rongyi Chen; Pingting Yang; Lindi Jiang
Journal:  Ther Adv Chronic Dis       Date:  2020-11-29       Impact factor: 5.091

4.  Induction of remission in a patient with Takayasu's arteritis by low dose pulses of methotrexate.

Authors:  D Mevorach; G Leibowitz; M Brezis; E Raz
Journal:  Ann Rheum Dis       Date:  1992-07       Impact factor: 19.103

5.  Methotrexate loaded SAE coated coronary stents reduce neointimal hyperplasia in a porcine coronary model.

Authors:  Y Huang; K Salu; X Liu; S Li; L Wang; E Verbeken; J Bosmans; I De Scheerder
Journal:  Heart       Date:  2004-02       Impact factor: 5.994

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.